Related Experiment Video
Updated: Jan 13, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
895
Increasing Obesity Rates Worldwide from 1976 to 2016: The Obesity Epidemic
Karsten Keller1,2, Volker H Schmitt1,3, Omar Hahad1,3
1Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.
Journal of Clinical Medicine
|January 10, 2026
Summary
Global obesity rates increased significantly between 1976 and 2016, with higher prevalence in females and notable regional disparities. This rise in obesity is linked to increased premature deaths worldwide.
Area of Science:
- Global Health
- Epidemiology
- Public Health
Background:
- Obesity is a critical global health issue, recognized as an epidemic by the World Health Organization (WHO).
- Understanding the temporal trends in obesity prevalence is crucial for public health interventions.
Purpose of the Study:
- To analyze worldwide temporal trends in adult obesity prevalence.
- To examine regional differences in obesity prevalence and its changes over time.
Main Methods:
- Utilized data from the WHO Global Health Observatory and the Global Burden of Disease (GBD) Study 2023.
- Analyzed crude obesity prevalence estimates for adults across WHO regions from 1976 to 2016.
Main Results:
- Obesity prevalence in 2016 was highest in the European and American regions (>20%), and lowest in African, Western Pacific, and South-East Asian regions (<10%).
- Significant increases in obesity prevalence were observed globally between 1976 and 2016, with the Americas and Europe showing the largest absolute increases.
- Obesity prevalence was consistently higher in females than males, and high Body Mass Index (BMI) is now a leading risk factor for mortality, linked to heart disease and diabetes.
Conclusions:
- Obesity prevalence varies regionally, with Europe and the Americas exhibiting the highest rates.
- Worldwide obesity prevalence has risen substantially between 1976 and 2016.
- Obesity is a growing contributor to premature mortality, particularly impacting females.
More Related Videos
Related Concept Videos
01:24Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
233
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
233
01:21Drug Dosing: Obese Patients
216
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
216
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
164
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
164
01:26Stress Prevention and Stress Management Techniques IV
221
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
221
01:24Overview of Lipid Metabolism
4.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.8K